系统性疾病唇部损害的诊断及临床处理

doi:10.7518/gjkq.2018.02.001

摘要/Abstract

摘要： 口腔黏膜病变是多种系统性疾病的常见表征,其中部分疾病可主要或者特异性地累及唇黏膜及唇周皮肤,因此本文对此类主要累及唇和唇周的疾病进行综述,以指导临床医生详细询问病史并完善相关检查,准确判断唇部病损产生的病因,从而收到更好的治疗效果。

关键词: 系统性疾病, 唇部表现, 治疗进展

Abstract: Oral mucosa lesions are the common manifestations of a variety of systemic diseases, some of these diseases can be major or specific skin involvement lip and around the lips, so this paper reviewed the main systemic diseases affected lip and around the lips, in order to guide the clinical doctor get a thorough history and physical examination, then to accurately determine the etiology of lip lesion, and receive better treatment effect.

Key words: systemic disease, labial performance, treatment progress

中图分类号:

R781.5+6

王智. 系统性疾病唇部损害的诊断及临床处理[J]. 国际口腔医学杂志, 2018, 45(2): 125-131.

Wang Zhi. Diagnosis and clinical treatment of labial injury of systemic diseases[J]. Inter J Stomatol, 2018, 45(2): 125-131.

参考文献

[1] 李敏, 宋文婷, 林梅. 炎症性肠病的口腔损害及其诊断[J]. 国际口腔医学杂志, 2010, 37(3):330-332.
Li M, Song WT, Lin M.Oral lesion of inflammatory bowel disease and its diagnosis[J]. Int J Stomatol, 2010, 37(3):330-332.
[2] Baumgart DC, Carding SR.Inflammatory bowel disease: cause and immunobiology[J]. Lancet, 2007, 369(9573):1627-1640.
[3] Atarashi K, Suda W, Luo C, et al.Ectopic coloni-zation of oral bacteria in the intestine drives T(H)1 cell induction and inflammation[J]. Science, 2017, 358(6361):359-365.
[4] Katsanos KH, Torres J, Roda G, et al.Review article: non-malignant oral manifestations in inflammatory bowel diseases[J]. Aliment Pharmacol Ther, 2015, 42(1):40-60.
[5] Álvarez-Garrido H, Pericet-Fernández L, Martínez-García G, et al.Crohn’s disease and cheilitis granu-lomatosa: role of silicone fillers[J]. J Am Acad Der-matol, 2011, 65(1):239-241.
[6] Stawarski A, Iwańczak B, Krzesiek E, et al.Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease[J]. Pol Merkur Lekarski, 2006, 20(115):22-25.
[7] Tan CX, Brand HS, de Boer NK, et al. Gastrointes-tinal diseases and their oro-dental manifestations: part 2: ulcerative colitis[J]. Br Dent J, 2017, 222(1):53-57.
[8] Lankarani KB, Sivandzadeh GR, Hassanpour S.Oral manifestation in inflammatory bowel disease: a review[J]. World J Gastroenterol, 2013, 19(46):8571-8579.
[9] Ciacci C, Bucci C, Zingone F, et al.Buccal localiza-tion of Crohn’s disease with long-term infliximab the-rapy: a case report[J]. J Med Case Rep, 2014, 8:397.
[10] Ben Salah R, Frikha F, Snoussi M, et al.Limited form of Wegener’s granulomatosis in a patient with Crohn’s disease. A case report[J]. Turk J Gastroenterol, 2014, 25(Suppl 1):191-195.
[11] Bohra S, Kariya PB, Bargale SD, et al.Clinicopatho-logical significance of Melkersson-Rosenthal syn-drome[J]. BMJ Case Rep, 2015, 2015:bcr2015210138.
[12] Sciubba JJ, Said-Al-Naief N. Orofacial granuloma-tosis: presentation, pathology and management of 13 cases[J]. J Oral Pathol Med, 2003, 32(10):576-585.
[13] Rivera-Serrano CM, Man LX, Klein S, et al.Melker-sson-Rosenthal syndrome: a facial nerve center perspective[J]. J Plast Reconstr Aesthet Surg, 2014, 67(8):1050-1054.
[14] Liu R, Yu S.Melkersson-Rosenthal syndrome: a review of seven patients[J]. J Clin Neurosci, 2013, 20(7):993-995.
[15] Dai C, Li J, Yang S, et al.Subtotal facial nerve decom-pression for recurrent facial palsy in Melkersson Ro-senthal syndrome[J]. Acta Otolaryngol, 2014, 134(4): 425-428.
[16] Ziem PE, Pfrommer C, Goerdt S, et al.Melkersson-Rosenthal syndrome in childhood: a challenge in differential diagnosis and treatment[J]. Br J Der-matol, 2000, 143(4):860-863.
[17] Okudo J, Oluyide Y.Melkersson-Rosenthal syndrome with orofacial swelling and recurrent lower motor neuron facial nerve palsy: a case report and review of the literature[J]. Case Rep Otolaryngol, 2015, 2015:214946.
[18] Liu R, Yu S.Melkersson-Rosenthal syndrome: a review of seven patients[J]. J Clin Neurosci, 2013, 20(7):993-995.
[19] Ziemssen F, Rohrbach JM, Scherwitz C, et al.Plastic reconstructive correction of persistent orofacial swe-lling and swelling of the eyelids in Melkersson-Rosenthal syndrome[J]. Klin Monbl Augenheilkd, 2003, 220(5):352-356.
[20] Kanerva M, Moilanen K, Virolainen S, et al.Melker-sson-Rosenthal syndrome[J]. Otolaryngol Head Neck Surg, 2008, 138(2):246-251.
[21] Chen ES, Moller DR.Etiologies of sarcoidosis[J]. Clin Rev Allergy Immunol, 2015, 49(1):6-18.
[22] Moller DR, Chen ES.What causes sarcoidosis[J]. Curr Opin Pulm Med, 2002, 8(5):429-434.
[23] Motswaledi MH, Khammissa RA, Jadwat Y, et al.Oral sarcoidosis: a case report and review of the literature[J]. Aust Dent J, 2014, 59(3):389-394.
[24] Zoon JJ.Chronic benign circumscript plasmocytic balanoposthitis[J]. Dermatologica, 1952, 105(1):1-7.
[25] Yang JH, Lee UH, Jang SJ, et al.Plasma cell cheilitis treated with intralesional injection of corticosteroids[J]. J Dermatol, 2005, 32(12):987-990.
[26] Tamaki K, Osada A, Tsukamoto K, et al.Treatment of plasma cell cheilitis with griseofulvin[J]. J Am Acad Dermatol, 1994, 30(5 Pt 1):789-790.
[27] Hanami Y, Motoki Y, Yamamoto T.Successful treat-ment of plasma cell cheilitis with topical tacrolimus: report of two cases[J]. Dermatol Online J, 2011, 17(2):6.
[28] Yamaguchi Y, Nishie W, Ito T, et al.Plasma cell cheilitis successfully treated with topical calcineurin inhibitors[J]. Eur J Dermatol, 2016, 26(6):609-610.
[29] Yoshimura K, Nakano S, Tsuruta D, et al.Successful treatment with 308-nm monochromatic excimer light and subsequent tacrolimus 0.03% ointment in re-fractory plasma cell cheilitis[J]. J Dermatol, 2013, 40(6):471-474.
[30] Madhavarajan S, Tighe J.Orofacial plasmacytosis: a management conundrum[J]. Br J Oral Maxillofac Surg, 2015, 53(4):399-402.
[31] Laffer WB.Blepharochalasis. Report of a case of this trophoneurosis, involving also the upper lip[J]. Cleveland Med J, 1909, 8:131-135.
[32] Ascher KW.Blepharochalasis mit struma und dop-pellippe[J]. Klin Monatsbl Augenheilkd, 1920, 65: 86-89.
[33] 郭丽丽, 刘林嶓. Ascher综合征的整形外科治疗[J]. 中国美容医学, 2009, 18(3):287-289.
Guo LL, Liu LB.Plastic surgical treatment in 16 cases of Ascher’s syndrome[J]. Chin J Aesth Med, 2009, 18(3):287-289.
[34] 董雪, 唐晓军. Ascher综合征[J]. 中国美容医学, 2012, 21(10):1886-1887.
Dong X, Tang XJ.Ascher syndrome[J]. Chin J Aesth Med, 2012, 21(10):1886-1887.
[35] Molina S, Medard P, Galdeano M.Ascher syndrome: report of a case with early manifestations[J]. Cranio-maxillofac Trauma Reconstr, 2015, 8(2):150-152.
[36] Beggs AD, Latchford AR, Vasen HF, et al.Peutz-Jeghers syndrome: a systematic review and recom-mendations for management[J]. Gut, 2010, 59(7): 975-986.
[37] 袁文娟, 曹丽珍. 口周色素沉着-肠息肉综合征[J]. 上海口腔医学, 2001, 10(4):319-320.
Yuan WJ, Cao LZ.Peutz-Jeghers syndrone: report of 4 cases[J]. Shanghai J Stomatol, 2001, 10(4):319-320.
[38] 张同贞, 温洪涛. 口周色素沉着-肠道息肉综合征的发病机制[J]. 肿瘤基础与临床, 2010, 23(6):541-543.
Zhang TZ, Wen HT.The pathogenesis of Peutz-Jeghers syndrome[J]. J Basic Clin Oncol, 2010, 23(6):541-543.
[39] Ge Y, Jia G, Lin T.Q-switched Nd:YAG laser treat-ment for labial lentigines associated with Peutz-Jeghers syndrome[J]. J Dtsch Dermatol Ges, 2015, 13(6):551-555.
[40] Løvås K, Husebye ES.Addison’s disease[J]. Lancet, 2005, 365(9476):2058-2061.
[41] Quinkler M.Addison’s disease[J]. Med Klin Inten-sivmed Notfmed, 2012, 107(6):454-459.
[42] Napier C, Pearce SH.Current and emerging thera-pies for Addison’s disease[J]. Curr Opin Endocrinol Diabetes Obes, 2014, 21(3):147-153.
[43] Michels A, Michels N.Addison disease: early detec-tion and treatment principles[J]. Am Fam Physician, 2014, 89(7):563-568.
[44] Laugier P, Hunziker N.Essential lenticular melanic pigmentation of the lip and cheek mucosa[J]. Arch Belg Dermatol Syphiligr, 1970, 26(3):391-399.
[45] Nikitakis NG, Koumaki D.Laugier-Hunziker syn-drome: case report and review of the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 116(1):e52-e58.
[46] Kemmett D, Ellis J, Spencer MJ, et al.The Laugier-Hunziker syndrome—a clinical review of six cases[J]. Clin Exp Dermatol, 1990, 15(2):111-114.
[47] Wei Z, Li GY, Ruan HH, et al.Laugier-Hunziker syndrome: a case report[J]. J Stomatol Oral Maxillo-fac Surg, 2017. [Epub ahead of print]
[48] Ko JH, Shih YC, Chiu CS, et al.Dermoscopic features in Laugier-Hunziker syndrome[J]. J Dermatol, 2011, 38(1):87-90.
[49] Sinha S, Schwartz RA.Juvenile acanthosis nigri-cans[J]. J Am Acad Dermatol, 2007, 57(3):502-508.
[50] Kutlubay Z, Engin B, Bairamov O, et al.Acanthosis nigricans: a fold (intertriginous) dermatosis[J]. Clin Dermatol, 2015, 33(4):466-470.
[51] 姚辉, 周曾同. 口腔黏膜黑棘皮病(附二例报告)[J]. 临床口腔医学杂志, 2010, 26(5):297-299.
Yao H, Zhou ZT.Acanthosis acanthosis in oral mucosa (report of two cases)[J]. J Clin Stomatol, 2010, 26(5):297-299.
[52] Canjuga I, Mravak-Stipetić M, Kopić V, et al.Oral acanthosis nigricans: case report and comparison with literature reports[J]. Acta Dermatovenerol Croat, 2008, 16(2):91-95.
[53] Hermanns-Lê T, Scheen A, Piérard GE.Acanthosis nigricans associated with insulin resistance: patho-physiology and management[J]. Am J Clin Dermatol, 2004, 5(3):199-203.
[54] Ezzedine K, Eleftheriadou V, Whitton M, et al.Vitiligo[J]. Lancet, 2015, 386(9988):74-84.
[55] Nagarajan A, Masthan MK, Sankar LS, et al.Oral manifestations of vitiligo[J]. Indian J Dermatol, 2015, 60(1):103.
[56] Rodrigues M, Ezzedine K, Hamzavi I, et al.Current and emerging treatments for vitiligo[J]. J Am Acad Dermatol, 2017, 77(1):17-29.
[57] 黄海艳, 王芳, 柯宜均, 等. 特殊部位白癜风的治疗进展[J]. 中国皮肤性病学杂志, 2013, 27(1):81-84.
Huang HY, Wang F, Ke YJ, et al.Advances in the treatment of vitiligo on special sites[J]. Chin J Derm Venereol, 2013, 27(1):81-84.
[58] Wang D, Goh BK.Noncultured epidermal cell suspension, in combination with carbon dioxide laser, improves punch grafting complications[J]. Dermatol Surg, 2017, 43(8):1100-1103.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed